NDLI: Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Please wait, while we are loading the content...

Epithelial cells expressing cytokeratins-19 and bone marrow micrometastases in patients with breast cancer at the time of primary surgery: clinical outcome during long-term follow-up

Pathological responses and survival of patients with human epidermal growth factor receptor 2-positive breast cancer who received neoadjuvant chemotherapy including trastuzumab.

Effect of progesterone receptor status on maspin synthesis via nitric oxide production in neutrophils in human breast cancer.

Procedures for location of non-palpable breast lesions: a systematic review for the radiologist.

Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients.

Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.

Reliability of frozen section in breast sentinel lymph node examination.

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients.

Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer.

GeneSearch™ BLN Assay could replace frozen section and touch imprint cytology for intra-operative assessment of breast sentinel lymph nodes.

Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.

Year: 2014 Volume: 21 Issue: 4

Year: 2014 Volume: 21 Issue: 3

Year: 2014 Volume: 21 Issue: 2

Year: 2014 Volume: 21 Issue: 1

Year: 2013 Volume: 20

Year: 2012 Volume: 19

Year: 2011 Volume: 18

Year: 2010 Volume: 17

Year: 2009 Volume: 16

Year: 2008 Volume: 15

Year: 1999 Volume: 6

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Kawai, Masaaki Suzuki, Akihiko Nishino, Yoshikazu Ohnuki, Koji Ishida, Takanori Amari, Masakazu Shibuya, Daisuke Ohuchi, Noriaki
Spatial Coverage	Japan
Description	Country affiliation: Japan Author Affiliation: Kawai M ( Department of Surgical Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.)
Abstract	BACKGROUND: The effectiveness of screening mammography (MMG) has mainly been demonstrated by studies in western countries. This study was conducted to evaluate cumulative survival and the risk of breast cancer death among Japanese women aged 40-69 years with screening-detected and interval breast cancer divided into three groups: MMG with clinical breast examination (CBE), CBE alone, and self-detection. METHODS: By matching a list of 126,537 women (358,242 person-screenings) who participated in the Miyagi Cancer Society Screening program between 1 April 1995 and 31 December 2002 with the Miyagi Prefectural Cancer Registry, 429 MMG with CBE, 522 CBE, and 3,047 self-detected cases were included in this study. Follow-up was performed until the date of death or 31 December 2007. Survival was estimated by the Kaplan-Meier method. The Cox proportional hazards model was used to estimate hazard ratios (HR) and 95 % confidence intervals (CI) for breast cancer death. RESULTS: Five-year survival for women in the MMG with CBE, CBE, and self-detection groups was 96.8, 92.7, and 86.6 %, respectively. The HR (95 % CI) for breast cancer death was 2.38 (0.72-7.94) among CBE-screened and 4.44 (1.42-13.89) among self-detected cases for women aged 40-49 years, but was 3.00 (1.63-5.50) among CBE-screened and 4.51 (2.69-7.56) among self-detected cases for women aged 50-69 years relative to cases screened by use of MMG with CBE. CONCLUSIONS: In terms of the survival and risk of breast cancer death, MMG with CBE may be more effective than MMG alone or self-detection for Japanese women aged 40-69 years.
File Format	HTM / HTML
ISSN	13406868
Issue Number	5
Volume Number	21
e-ISSN	18804233
Journal	Breast Cancer
Language	English
Publisher	Springer
Publisher Date	2014-09-01
Publisher Place	Japan
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Oncology Breast Neoplasms Mortality Mass Screening Adult Aged Asian Continental Ancestry Group Prevention & Control Early Detection Of Cancer Female Humans Japan Epidemiology Kaplan-meier Estimate Mammography Middle Aged Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Radiology, Nuclear Medicine and Imaging Pharmacology (medical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Breast cancer screening and the changing population pyramid of Japan.

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Lung cancer survival among black and white patients in an equal access health system.

Protection of mammography screening against death from breast cancer in women aged 40–64 years

Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.

How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?

Black women in US have lower survival rates from breast cancer than white women.

Outcomes in black patients with early breast cancer treated with breast conservation therapy.

Efficacy of Screening Mammography Among Women Aged 40 to 49 Years and 50 to 69 Years: Comparison of Relative and Absolute Benefit

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Similar Documents

Breast cancer screening and the changing population pyramid of Japan.

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Lung cancer survival among black and white patients in an equal access health system.

Protection of mammography screening against death from breast cancer in women aged 40–64 years

Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.

How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?

Black women in US have lower survival rates from breast cancer than white women.

Outcomes in black patients with early breast cancer treated with breast conservation therapy.

Efficacy of Screening Mammography Among Women Aged 40 to 49 Years and 50 to 69 Years: Comparison of Relative and Absolute Benefit

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.